EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY

被引：0
|
作者：
Saliba, Faouzi [1 ]
De Simone, Paolo [2 ]
Nevens, Frederik [3 ]
De Carlis, Luciano [4 ]
Metselaar, Herold [5 ]
Beckebaum, Susanne [6 ]
Jonas, Sven [7 ]
Sudan, Debra [8 ]
Fischer, Lutz [9 ]
Fung, John J. [10 ]
Jiang, Hai [11 ]
Junge, Guido [12 ]
机构：
[1] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France
[2] Azienda Osped Univ Pisana, Pisa, Italy
[3] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[4] Osped Niguarda Ca Granda, Milan, Italy
[5] Univ Hosp Rotterdam, Erasmus MC, Rotterdam, Netherlands
[6] Univ Hosp Essen, Essen, Germany
[7] Univ Med Ctr Leipzig, Leipzig, Germany
[8] Duke Univ, Med Ctr, Durham, NC USA
[9] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[11] Novartis Pharmaceut, E Hanover, NJ USA
[12] Novartis Pharma AG, Basel, Switzerland
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1430A / 1431A
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Everolimus with Reduced Tacrolimus or Cyclosporine in Pediatric Liver Transplant Recipients: 12-Month Results from H2305 Study
    Weymann, A.
    Ganschow, R.
    Ericzon, B.
    Dhawan, A.
    Sharif, K.
    Martzloff, E. -D.
    Rauer, B.
    Ng, J.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 234 - 234
  • [32] Improvement of renal function with everolimus plus reduced tacrolimus in de novo liver transplant recipients - HEPHAISTOS study 12 month data.
    Schlitt, H. J.
    Nashan, B.
    Braun, F.
    Pascher, A.
    Klein, C. -G
    Neumann, U.
    Kroeger, I
    Wimmer, P.
    Schemmer, P.
    TRANSPLANTATION, 2019, 103 (08) : 46 - 46
  • [33] Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients
    Vitko, S
    Margreiter, R
    Weimar, W
    Dantal, J
    Viljoen, HG
    Li, YL
    Jappe, A
    Cretin, N
    TRANSPLANTATION, 2004, 78 (10) : 1532 - 1540
  • [34] EARLY EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS: DESIGN AND BASELINE DATA FROM HEPHAISTOS STUDY
    Nashan, B.
    Schemmer, P.
    Braun, F.
    Dworak, M.
    Wimmer, P.
    Schlitt, H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S850 - S850
  • [35] Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART
    Potena, L.
    Barberini, F.
    Boffini, M.
    Amarelli, C.
    Pellegrini, C.
    Livi, U.
    Masciocco, G.
    Faggian, G.
    Gerosa, G.
    Lilla, P.
    Marraudino, N.
    Porcu, M.
    Guarisco, R.
    Maccherini, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S136 - S136
  • [36] Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study (vol 18, pg 1435, 2018)
    Jeng, L-B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (10) : 2489 - 2490
  • [37] Delayed Introduction of Everolimus Versus Tacrolimus in de Novo Liver Transplant Recipients: Safety Events of Interest with Everolimus Use
    Fischer, L.
    Chavin, K.
    Huang, M. A.
    Kozlowski, T.
    Dong, G.
    Lopez, P.
    Junge, G.
    De Carlis, L.
    TRANSPLANTATION, 2012, 94 (10) : 48 - 48
  • [38] EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    Saliba, F.
    Metselaar, H. J.
    Beckebaum, S.
    Duvoux, C.
    Navasa, M.
    Dong, G.
    Lopez, P.
    Nevens, F.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S79 - S80
  • [39] Hephaistos Study Outcome on Renal Function after 12 Month Everolimus Plus Reduced Tacrolimus in De Novo Liver Transplant Recipients versus Standard Tacrolimus.
    Braun, F.
    Schemmer, P.
    Schlitt, H.
    Pascher, A.
    Klein, C.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Nashan, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 556 - 556
  • [40] Efficacy and Safety of Everolimus With Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplant: Design of a Randomized Study
    Grant, D.
    Levy, G.
    Song, G.
    Chen, C.
    Lee, W.
    Joh, J.
    Speziale, A.
    Rauer, B.
    Wang, Z.
    Junge, G.
    Uemoto, S.
    Suh, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 781 - 782
12345